A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet.

We have used total enteral nutrition (TEN) to moderately overfeed rats high-polyunsaturated fat diets to develop a model for nonalcoholic steatohepatitis (NASH). Male Sprague-Dawley rats were fed by TEN a 187 kcal.kg(-3/4).day(-1) diet containing 5% (total calories) corn oil or a 220 kcal.kg(-3/4).day(-1) diet in which corn oil constituted 5, 10, 25, 35, 40, or 70% of total calories for 21 or 65 days. Rats fed the 5% corn oil, 220 kcal.kg(-3/4).day(-1)diet had greater body weight gain (P < or = 0.05), fat mass (P < or = 0.05), and serum leptin and glucose levels (P < or = 0.05), but no liver pathology. A dose-dependent increase in hepatic triglyceride deposition occurred with increase in percent corn oil in the 220 kcal.kg(-3/4).day(-1) groups (P < or = 0.05). Steatosis, macrophage infiltration, apoptosis, and focal necrosis were present in the 70% corn oil group, accompanied by elevated serum alanine aminotransferase (ALT) levels (P < or = 0.05). An increase in oxidative stress (thiobarbituric acid-reactive substances) and TNF-alpha expression (P < or = 0.05) was observed in the 70% corn oil group, as well as an increase in hepatic CYP2E1 and CYP4A1 expression (P < or = 0.05). Significant positive correlations were observed between the level of dietary corn oil and the degree of pathology, ALTs, oxidative stress, and inflammation. Liver pathology was progressive with increased necrosis, accompanied by fibrosis, observed after 65 days of TEN. Increased expression of CD36 and l-fabp mRNA suggested development of steatosis was associated with increased fatty acid transport. These data suggest that intragastric infusion of a high-polyunsaturated fat diet at a caloric level of 17% excess total calories results in pathology similar to clinical NASH.

[1]  M. Czaja.  Liver injury in the setting of steatosis: Crosstalk between adipokine and cytokine , 2004, Hepatology.

[2]  R. Poulsom.  Morphological changes of organs after sucrose or fructose feeding. , 1986, Progress in biochemical pharmacology.

[3]  M. Pagliassotti,et al.  Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. , 2006, Endocrinology.

[4]  E. Fisher,et al.  Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production. , 2004, The Journal of clinical investigation.

[5]  E. Fisher,et al.  Apolipoprotein B100 Exit from the Endoplasmic Reticulum (ER) Is COPII-dependent, and Its Lipidation to Very Low Density Lipoprotein Occurs Post-ER* , 2003, Journal of Biological Chemistry.

[6]  H. A. Masson,et al.  Multiple forms of hepatic cytochrome P-450. Purification, characterisation and comparison of a novel clofibrate-induced isozyme with other major forms of cytochrome P-450. , 1984, European journal of biochemistry.

[7]  M. Miyazaki,et al.  Regulation of stearoyl-CoA desaturases and role in metabolism. , 2004, Progress in lipid research.

[8]  J. Maher.  Alcoholic steatosis and steatohepatitis. , 2002, Seminars in gastrointestinal disease.

[9]  G. Marchesini,et al.  Nutritional support with amino acids in advanced cirrhosis: a few answers, a lot of questions. , 1999, Nutrition.

[10]  V. Zammit.  Insulin Stimulation of Hepatic Triacylglycerol Secretion in the Insulin‐Replete State , 2002, Annals of the New York Academy of Sciences.

[11]  C. Day,et al.  Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.

[12]  Xianlin Han,et al.  Decreased Hepatic Triglyceride Accumulation and Altered Fatty Acid Uptake in Mice with Deletion of the Liver Fatty Acid-binding Protein Gene* , 2003, Journal of Biological Chemistry.

[13]  J. Clore,et al.  Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. , 2001, Gastroenterology.

[14]  D. V. van Thiel,et al.  Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. , 2002, Nutrition reviews.

[15]  T. Okumura,et al.  Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice. , 2005, Biochemical and biophysical research communications.

[16]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference , 2003, Hepatology.

[17]  M. Roberts,et al.  Fatty acid binding protein is a major determinant of hepatic pharmacokinetics of palmitate and its metabolites. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[18]  J. Rodin,et al.  Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. , 1995, Metabolism: clinical and experimental.

[19]  I. Leclercq,et al.  Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[20]  Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis , 2003, Hepatology.

[21]  N. Chalasani,et al.  Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis , 2003, Hepatology.

[22]  I. Wanless,et al.  Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors , 1990, Hepatology.

[23]  I. Leclercq,et al.  CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. , 2000, The Journal of clinical investigation.

[24]  G. Musso,et al.  Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis , 2003, Hepatology.

[25]  C. García-Monzón,et al.  Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. , 2000, Journal of hepatology.

[26]  H. Cortez‐Pinto,et al.  Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. , 1999, JAMA.

[27]  H. Yoshimatsu,et al.  TNF-α Induces Hepatic Steatosis in Mice by Enhancing Gene Expression of Sterol Regulatory Element Binding Protein-1c (SREBP-1c) , 2007, Experimental biology and medicine.

[28]  R. E. Pitas,et al.  Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1 s⃞ Published, JLR Papers in Press, July 8, 2006. , 2006, Journal of Lipid Research.

[29]  A. Cederbaum,et al.  A high‐fat diet leads to the progression of non‐alcoholic fatty liver disease in obese rats , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  B. Luxon,et al.  Induction of hepatic cytosolic fatty acid binding protein with clofibrate accelerates both membrane and cytoplasmic transport of palmitate. , 2000, Biochimica et biophysica acta.

[31]  J. Lemasters,et al.  Mitochondrial Oxygen Radical Formation during Reductive and Oxidative Stress to Intact Hepatocytes , 1997, Bioscience reports.

[32]  A. Nanji,et al.  Dietary saturated fatty acids reverse inflammatory and fibrotic changes in rat liver despite continued ethanol administration. , 2001, The Journal of pharmacology and experimental therapeutics.

[33]  S. Korourian,et al.  Undernutrition enhances alcohol-induced hepatocyte proliferation in the liver of rats fed via total enteral nutrition. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[34]  S. Seki,et al.  In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. , 2002, Journal of hepatology.

[35]  P. Galtier,et al.  Peroxisome Proliferator-activated Receptor α-Isoform Deficiency Leads to Progressive Dyslipidemia with Sexually Dimorphic Obesity and Steatosis* , 1998, The Journal of Biological Chemistry.

[36]  L. Romics,et al.  Diverse regulation of NF‐κB and peroxisome proliferator‐activated receptors in murine nonalcoholic fatty liver , 2004, Hepatology.

[37]  M. Ronis,et al.  Dietary saturated fat reduces alcoholic hepatotoxicity in rats by altering fatty acid metabolism and membrane composition. , 2004, The Journal of nutrition.

[38]  D. Crabb,et al.  Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice , 2005, Hepatology.

[39]  J. Crespo,et al.  Gene expression of tumor necrosis factor α and TNF‐receptors, p55 and p75, in nonalcoholic steatohepatitis patients , 2001 .

[40]  D. Koop,et al.  Steatohepatitis induced by intragastric overfeeding in mice , 2005, Hepatology.

[41]  A. Gasbarrini,et al.  Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test , 2003, American Journal of Gastroenterology.

[42]  S. Caldwell,et al.  Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease , 1999, Hepatology.

[43]  X. Deng,et al.  Increased hepatic VLDL secretion, lipogenesis, and SREBP-1 expression in the corpulent JCR:LA-cp rat. , 2001, Journal of lipid research.

[44]  K. Shankar,et al.  Mechanisms and Outcomes of Drug- and Toxicant-Induced Liver Toxicity in Diabetes , 2007, Critical reviews in toxicology.

[45]  M. Holness,et al.  The short-term regulation of hepatic acetyl-CoA carboxylase during starvation and re-feeding in the rat. , 1991, The Biochemical journal.

[46]  D. Pessayre,et al.  Inhibition of microsomal triglyceride transfer protein: Another mechanism for drug‐induced steatosis in mice , 2003, Hepatology.

[47]  R. Hammer,et al.  Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. , 1996, The Journal of clinical investigation.

[48]  Cai Li,et al.  Leptin: a multifunctional hormone , 2000, Cell Research.

[49]  K. Mak,et al.  Model of nonalcoholic steatohepatitis. , 2004, The American journal of clinical nutrition.

[50]  G. Gores,et al.  O0040 FREE FATTY ACIDS PROMOTE HEPATIC LIPOTOXICITY BY STIMULATING TNF‐ALPHA EXPRESSION VIA A LYSOSOMAL PATHWAY , 2004, Journal of Pediatric Gastroenterology and Nutrition.

[51]  G. Gores,et al.  Free fatty acids promote hepatic lipotoxicity by stimulating TNF‐α expression via a lysosomal pathway , 2004 .

[52]  O. Uygur-Bayramiçli,et al.  Is adiponectin level a predictor of nonalcoholic fatty liver disease in nondiabetic male patients? , 2005, World journal of gastroenterology.

[53]  D. Jump,et al.  Fatty acid regulation of hepatic gene transcription. , 2005, The Journal of nutrition.

[54]  I. Leclercq,et al.  NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis. , 2005, Gastroenterology.

[55]  J. Kim,et al.  Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPARα , 2004, Molecular and Cellular Endocrinology.

[56]  M. Ingelman-Sundberg,et al.  Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis , 1998, Hepatology.

[57]  M. Ingelman-Sundberg,et al.  Benzene metabolism by ethanol-, acetone-, and benzene-inducible cytochrome P-450 (IIE1) in rat and rabbit liver microsomes. , 1988, Cancer research.

[58]  E. Fisher,et al.  Complexity in the Secretory Pathway: The Assembly and Secretion of Apolipoprotein B-containing Lipoproteins* , 2002, The Journal of Biological Chemistry.

[59]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[60]  M. Vidali,et al.  Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis , 2005, Gut.

[61]  Bing Zhang,et al.  GOTree Machine (GOTM): a web-based platform for interpreting sets of interesting genes using Gene Ontology hierarchies , 2004, BMC Bioinformatics.

[62]  F. Burczynski,et al.  Enhanced expression of cytosolic fatty acid binding protein and fatty acid uptake during liver regeneration in rats , 2004, Molecular and Cellular Biochemistry.

[63]  A. Moser,et al.  Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease , 2003, Hepatology.

[64]  大川 博,et al.  Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction , 1979 .

[65]  D. Gašperíková,et al.  Fatty Acid Regulation of Gene Expression , 2002 .

[66]  G. Gores,et al.  Apoptosis and necrosis in the liver: A tale of two deaths? , 2006, Hepatology.

[67]  A. A. Reilly,et al.  Hepatic Gene Expression Changes in Mouse Models with Liver-specific Deletion or Global Suppression of the NADPH-Cytochrome P450 Reductase Gene , 2005, Journal of Biological Chemistry.

[68]  J. Schaffer,et al.  Lipotoxicity: when tissues overeat , 2003, Current opinion in lipidology.

[69]  M. Weltman,et al.  Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. , 1996, Gastroenterology.

[70]  M. Czaja,et al.  Hepatocyte CYP2E1 Overexpression and Steatohepatitis Lead to Impaired Hepatic Insulin Signaling* , 2005, Journal of Biological Chemistry.

[71]  M. Ingelman-Sundberg,et al.  Effects of short-term ethanol and nutrition on the hepatic microsomal monooxygenase system in a model utilizing total enteral nutrition in the rat. , 1991, Alcoholism, clinical and experimental research.

[72]  M. Ingelman-Sundberg,et al.  Induction, suppression and inhibition of multiple hepatic cytochrome P450 isozymes in the male rat and bobwhite quail (Colinus virginianus) by ergosterol biosynthesis inhibiting fungicides (EBIFs). , 1994, Biochemical pharmacology.

[73]  J. Kench,et al.  Beyond insulin resistance in NASH: TNF‐α or adiponectin? , 2004, Hepatology.

[74]  A. Bonen,et al.  Effects of cAMP modulators on long-chain fatty-acid uptake and utilization by electrically stimulated rat cardiac myocytes. , 2002, The Biochemical journal.

[75]  M. Ingelman-Sundberg,et al.  Human liver microsomal cytochrome P-450IIE1. Immunological evaluation of its contribution to microsomal ethanol oxidation, carbon tetrachloride reduction and NADPH oxidase activity. , 1989, Biochemical pharmacology.

[76]  M. Ingelman-Sundberg,et al.  Pulsatile blood alcohol and CYP2E1 induction during chronic alcohol infusions in rats. , 1993, Alcohol.

[77]  M. Ingelman-Sundberg,et al.  Effects of N-acetylcysteine on ethanol-induced hepatotoxicity in rats fed via total enteral nutrition. , 2005, Free radical biology & medicine.

[78]  A. Nanji.  Role of different dietary fatty acids in the pathogenesis of experimental alcoholic liver disease. , 2004, Alcohol.

[79]  M. Ingelman-Sundberg,et al.  Effects of chronic ethanol on growth hormone secretion and hepatic cytochrome P450 isozymes of the rat. , 1993, The Journal of pharmacology and experimental therapeutics.

[80]  H. Mehendale,et al.  Chronic Ethanol Intake Impairs Insulin Signaling in Rats by Disrupting Akt Association with the Cell Membrane , 2006, Journal of Biological Chemistry.

[81]  K. Nair,et al.  Apolipoprotein synthesis in nonalcoholic steatohepatitis , 2002, Hepatology.

[82]  S. Friedman,et al.  Leptin in hepatic fibrosis: Evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice , 2002, Hepatology.

[83]  G. Farrell,et al.  Nonalcoholic fatty liver disease: From steatosis to cirrhosis , 2006, Hepatology.

[84]  J. Girard,et al.  Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver. , 2005, Biochimie.

[85]  R. Rodrigo,et al.  Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. , 2004, Clinical science.

[86]  J. Girard,et al.  Hepatic gene regulation by glucose and polyunsaturated fatty acids: a role for ChREBP. , 2006, Journal of NutriLife.

[87]  T. Okumura,et al.  Increased expression of PPARγ in high fat diet-induced liver steatosis in mice , 2005 .

[88]  T. Badger,et al.  Episodic excretion of ethanol during chronic intragastric ethanol infusion in the male rat: continuous vs. cyclic ethanol and nutrient infusions. , 1993, The Journal of pharmacology and experimental therapeutics.

[89]  H. Yoshiji,et al.  Leptin‐mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats , 2006, Hepatology.

[90]  C. Day.  Pathogenesis of steatohepatitis. , 2002, Best practice & research. Clinical gastroenterology.

[91]  H. Cortez‐Pinto,et al.  Non-alcoholic steatohepatitis: from cell biology to clinical practice. , 2006, Journal of hepatology.